Search Results - "SUZHAN ZHANG"
-
1
Ferroptosis in Cancer Treatment: Another Way to Rome
Published in Frontiers in oncology (25-09-2020)“…Ferroptosis is a newly described type of programmed cell death and intensively related to both maintaining homeostasis and the development of diseases,…”
Get full text
Journal Article -
2
Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis
Published in BMJ open (08-04-2015)“…Objective Increasing evidence suggests that cancer-associated inflammation is associated with poor prognosis in patients with cancer. The role of the…”
Get full text
Journal Article -
3
Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies
Published in Scientific reports (31-12-2022)“…Adjuvant endocrine therapy improves the prognosis of early breast cancer with hormone receptor positivity. However, there is no systematic report on the effect…”
Get full text
Journal Article -
4
Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2′-deoxyguanosine by UPLC-MS/MS Analysis
Published in Scientific reports (02-09-2016)“…Oxidative DNA damage plays crucial roles in the pathogenesis of numerous diseases including cancer. 8-hydroxy-2′-deoxyguanosine (8-OHdG) is the most…”
Get full text
Journal Article -
5
The Role of lncRNAs in the Distant Metastasis of Breast Cancer
Published in Frontiers in oncology (31-05-2019)“…Breast cancer (BC) remains the most frequently diagnosed cancer worldwide. Among breast cancer patients, distant metastasis and invasion is the leading cause…”
Get full text
Journal Article -
6
Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer
Published in Molecular cancer research (01-03-2018)“…Increasing evidence suggests that left-sided colon cancer (LCC) and right-sided colon cancer (RCC) are emerging as two different colorectal cancer types with…”
Get full text
Journal Article -
7
Dual targeted therapy with pyrotinib and trastuzumab for HER2‐positive advanced colorectal cancer: A phase 2 trial
Published in Cancer science (01-03-2023)“…This trial was initiated to evaluate the efficacy and safety of pyrotinib in combination with trastuzumab in patients with human epidermal growth factor…”
Get full text
Journal Article -
8
CSCO guidelines for colorectal cancer version 2022: Updates and discussions
Published in Chinese journal of cancer research (30-04-2022)Get full text
Journal Article -
9
Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis
Published in PloS one (23-02-2015)“…MicroRNA-21 (miRNA-21 or miR-21) may act as a prognostic biomarker of cancer. However, the available evidence is controversial. Therefore, the present…”
Get full text
Journal Article -
10
Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer
Published in Protein & cell (01-08-2016)“…Oxaliplatin is a key drug in chemotherapy of colorectal cancer (CRC). However, its efficacy is unsatisfied due to drug resistance of cancer ceils. In this…”
Get full text
Journal Article -
11
Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage
Published in Frontiers in psychiatry (17-12-2018)“…The relationship between depression and intracerebral hemorrhage (ICH) is complicated. One of the most common neuropsychiatric comorbidities of hemorrhagic…”
Get full text
Journal Article -
12
Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020
Published in Chinese journal of cancer research (30-06-2021)Get full text
Journal Article -
13
PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
Published in Cell death & disease (07-03-2018)“…Osteosarcoma (OS) is the most common primary malignant bone tumor mainly occurring in children and adolescents. In past decades, studies revealed that PARK2…”
Get full text
Journal Article -
14
Potential application of the oxidative nucleic acid damage biomarkers in detection of diseases
Published in Oncotarget (26-09-2017)“…Reactive oxygen species (ROS) are generated after exposure to harmful environmental factors and during normal cellular metabolic processes. The balance of the…”
Get full text
Journal Article -
15
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study
Published in BMC cancer (18-07-2023)“…Rat sarcoma viral oncogene homolog (RAS) gene mutation is a common molecular event in colorectal cancer (CRC). The prognosis of mCRC (metastatic colorectal…”
Get full text
Journal Article -
16
Common genetic variation in ETV6 is associated with colorectal cancer susceptibility
Published in Nature communications (05-05-2016)“…Genome-wide association studies (GWASs) have identified multiple susceptibility loci for colorectal cancer, but much of heritability remains unexplained. To…”
Get full text
Journal Article -
17
The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment
Published in PloS one (08-07-2016)“…Breast cancer is a worldwide threat to female health with patient outcomes varying widely. The exact correlation between global outcomes of breast cancer and…”
Get full text
Journal Article -
18
Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers
Published in Clinical cancer research (15-04-2011)“…This study aims to address the hypothesis that the high-mobility group A2 (HMGA2), an oncofetal protein, relates to survivability and serves as a prognostic…”
Get full text
Journal Article -
19
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)
Published in Journal of cancer research and clinical oncology (01-03-2019)“…The liver is the most common anatomical site for hematogenous metastases of colorectal cancer, and colorectal liver metastases is one of the most difficult and…”
Get full text
Journal Article -
20
PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer
Published in Frontiers in oncology (23-08-2019)“…mutation is originally associated with the progression of Parkinson's disease. In recent years, has been reported as a tumor suppressor gene in various…”
Get full text
Journal Article